Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
Stopped early · Phase 1/Phase 2
Conditions studied: Carcinoma, Hepatocellular, Hepatobiliary Neoplasm, Liver Carcinoma
In brief
To determine the efficacy and toxicity of TACE combined with SBRT
Key facts
- Study ID
- NCT01020812
- Run by
- Stanford University
- People needed
- 11
- Starts
- 2009-09-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2016-07-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.